Ignite Creation Date:
2025-12-25 @ 12:14 AM
Ignite Modification Date:
2026-02-23 @ 12:22 PM
Study NCT ID:
NCT05605158
Status:
UNKNOWN
Last Update Posted:
2022-11-04
First Post:
2022-10-30
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Comparative Clinical Study Between Empagliflozin Versus Pioglitazone in Non-diabetic Patients With Non-alcoholic Steatohepatitis
Sponsor:
Tanta University
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Non Alcoholic Steatohepatitis | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | NASH | View |
| None | Nonalcoholic fatty liver disease (NAFLD) | View |
| None | SGLT2i | View |
| None | Empagliflozin | View |
| None | Pioglitazone | View |
| None | Hepatic steatosis index (HSI) | View |
| None | Fibrosis index based on the 4 factors (FIB-4) | View |
| None | Aspartate transaminase-to-platelet ratio index (APRI) | View |
| None | Cytokeratin-18 | View |
| None | Transforming growth factor-beta1 (TGF-β1) | View |
| None | Malondialdehyde (MDA) | View |